Literature DB >> 19659569

Rosai-Dorfman disease with massive intracranial involvement: asymmetric response to conservative therapy.

Robert N Walker1, Thomas P Nickles, Nektarios I Lountzis, Darren L Jacobs, Nava K Nawaz.   

Abstract

Rosai-Dorfman Disease (RDD) is a rare, idiopathic lymphoproliferative disorder. Central nervous system (CNS) involvement in this disorder is an uncommon manifestation. The clinical and radiographic appearance of CNS RDD is variable, and may mimic more common diseases. Treatment is controversial, and spontaneous remission is common. Positive outcomes have been reported with radiation therapy, or corticosteroid administration, or surgical excision. Our case is unusual in that the extracranial sites of involvement responded to corticosteroid therapy while the intracranial masses progressed.
Copyright © 2009 by the American Society of Neuroimaging.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 19659569     DOI: 10.1111/j.1552-6569.2009.00404.x

Source DB:  PubMed          Journal:  J Neuroimaging        ISSN: 1051-2284            Impact factor:   2.486


  3 in total

Review 1.  Rosai-Dorfman disease of the central nervous system: report of 6 cases and review of the literature.

Authors:  Jose D Sandoval-Sus; Ana C Sandoval-Leon; Jennifer R Chapman; Jose Velazquez-Vega; Maria J Borja; Shai Rosenberg; Alexander Lossos; Izidore S Lossos
Journal:  Medicine (Baltimore)       Date:  2014-05       Impact factor: 1.889

2.  Rosai-Dorfman disease mimicking images of meningiomas: Two case reports and literature review.

Authors:  Rafael Trindade Tatit; Paulo Eduardo Albuquerque Zito Raffa; Giovana Cassia de Almeida Motta; André Alexandre Bocchi; Júlia Loripe Guimaraes; Paulo Roberto Franceschini; Paulo Henrique Pires de Aguiar
Journal:  Surg Neurol Int       Date:  2021-06-21

3.  Long-term follow-up in two cases of intracranial Rosai-Dorfman Disease complicated by incomplete resection and recurrence.

Authors:  Diones Rivera; Miguelina Pérez-Castillo; Belkis Fernández; Peter Stoeter
Journal:  Surg Neurol Int       Date:  2014-02-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.